Clinical Trial Update: Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ribavirin in combination with Pegasys (pegylated interferon alfa-2a) for recurrent hepatitis C after liver transplantation h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED